Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry

BACKGROUND: Where health economic studies are frequently performed using modelling, with input from randomized controlled trials and best guesses, we used real-life data to analyse the cost-effectiveness and cost-utility of a treatment strategy aiming to the target of remission compared to usual car...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vermeer, Marloes, Kievit, Wietske, Kuper, Hillechiena H, Braakman-Jansen, Louise MA, Bernelot Moens, Hein J, Zijlstra, Theo R, den Broeder, Alfons A, van Riel, Piet LCM, Fransen, Jaap, van de Laar, Mart AFJ
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3884120/
https://ncbi.nlm.nih.gov/pubmed/24330489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-14-350
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados